Treatment of Hypogonadism: Current and Future Therapies

The treatment of hypogonadism in men is of great interest to both patients and providers. There are a number of testosterone formulations currently available and several additional formulations under development. In addition, there are some lesser-used alternative therapies for the management of mal...

Descripción completa

Detalles Bibliográficos
Autores principales: Thirumalai, Arthi, Berkseth, Kathryn E., Amory, John K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265703/
https://www.ncbi.nlm.nih.gov/pubmed/28149506
http://dx.doi.org/10.12688/f1000research.10102.1
_version_ 1782500320143736832
author Thirumalai, Arthi
Berkseth, Kathryn E.
Amory, John K.
author_facet Thirumalai, Arthi
Berkseth, Kathryn E.
Amory, John K.
author_sort Thirumalai, Arthi
collection PubMed
description The treatment of hypogonadism in men is of great interest to both patients and providers. There are a number of testosterone formulations currently available and several additional formulations under development. In addition, there are some lesser-used alternative therapies for the management of male hypogonadism, which may have advantages for certain patient groups. The future of hypogonadism therapy may lie in the development of selective androgen receptor modulators that allow the benefits of androgens whilst minimizing unwanted side effects.
format Online
Article
Text
id pubmed-5265703
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-52657032017-01-31 Treatment of Hypogonadism: Current and Future Therapies Thirumalai, Arthi Berkseth, Kathryn E. Amory, John K. F1000Res Review The treatment of hypogonadism in men is of great interest to both patients and providers. There are a number of testosterone formulations currently available and several additional formulations under development. In addition, there are some lesser-used alternative therapies for the management of male hypogonadism, which may have advantages for certain patient groups. The future of hypogonadism therapy may lie in the development of selective androgen receptor modulators that allow the benefits of androgens whilst minimizing unwanted side effects. F1000Research 2017-01-23 /pmc/articles/PMC5265703/ /pubmed/28149506 http://dx.doi.org/10.12688/f1000research.10102.1 Text en Copyright: © 2017 Thirumalai A et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Thirumalai, Arthi
Berkseth, Kathryn E.
Amory, John K.
Treatment of Hypogonadism: Current and Future Therapies
title Treatment of Hypogonadism: Current and Future Therapies
title_full Treatment of Hypogonadism: Current and Future Therapies
title_fullStr Treatment of Hypogonadism: Current and Future Therapies
title_full_unstemmed Treatment of Hypogonadism: Current and Future Therapies
title_short Treatment of Hypogonadism: Current and Future Therapies
title_sort treatment of hypogonadism: current and future therapies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265703/
https://www.ncbi.nlm.nih.gov/pubmed/28149506
http://dx.doi.org/10.12688/f1000research.10102.1
work_keys_str_mv AT thirumalaiarthi treatmentofhypogonadismcurrentandfuturetherapies
AT berksethkathryne treatmentofhypogonadismcurrentandfuturetherapies
AT amoryjohnk treatmentofhypogonadismcurrentandfuturetherapies

Ejemplares similares